Palvella Therapeutics
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Community Salary Data
Help build salary transparency at Palvella Therapeutics. Share your compensation anonymously.
Reviews
Founders
News
Jobs
About Palvella Therapeutics
Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORINTM platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORINTM rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations. For more information, please go to www.palvellatx.com.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2015
- Headquarters
- Wayne
Why Work at Palvella Therapeutics?
Discover what makes Palvella Therapeutics a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
